Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review., 20319 [2013-07827]

Download as PDF wreier-aviles on DSK5TPTVN1PROD with NOTICES Federal Register / Vol. 78, No. 65 / Thursday, April 4, 2013 / Notices related dementias on people with the disease and their caregivers. During the April meeting, the Advisory Council will hear a presentation from an international partner on their efforts to address Alzheimer’s disease. There will be a presentation on the priorities set during the May 2012 research summit and the milestones for achieving the 2025 goal. The federal partners will provide an update on progress implementing the National Plan to Address Alzheimer’s Disease and discuss highlights of the 2013 Update to the National Plan. DATES: The meeting will be held on April 29, 2013 from 9:00 am to 5:00 pm EDT. ADDRESSES: The meeting will be held at the U.S. Department of Health and Human Services, 200 Independence Avenue SW., Room 800, Washington, DC 20201. Comments: Time is allocated on the agenda to hear public comments. In lieu of oral comments, formal written comments may be submitted for the record to Helen Lamont, Ph.D., OASPE, 200 Independence Avenue SW., Room 424E, Washington, DC 20201. Comments may also be sent to napa@hhs.gov. Those submitting written comments should identify themselves and any relevant organizational affiliations. FOR FURTHER INFORMATION CONTACT: Helen Lamont, Ph.D. (202) 690–7996, helen.lamont@hhs.gov. Note: Seating may be limited. Those wishing to attend the meeting must send an email to napa@hhs.gov and put ‘‘April 29 meeting attendance’’ in the Subject line by Friday, April 19, 2013, so that their names may be put on a list of expected attendees and forwarded to the security officers at the Department of Health and Human Services. Any interested member of the public who is a non-U.S. citizen should include this information at the time of registration to ensure that the appropriate security procedure to gain entry to the building is carried out. Although the meeting is open to the public, procedures governing security and the entrance to Federal buildings may change without notice. If you wish to make a public comment, you must note that within your email. SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)). Topics of the Meeting: The Advisory Council will hear a presentation from an international partner on their efforts to address Alzheimer’s disease and will discuss ways to collaboration internationally. VerDate Mar<15>2010 14:48 Apr 03, 2013 Jkt 229001 20319 There will be a presentation on the priorities set during the May 2012 research summit and the milestones for achieving the 2025 goal. The federal partners will provide an update on progress implementing the National Plan to Address Alzheimer’s Disease and discuss highlights of the 2013 Update to the National Plan. Procedure and Agenda: This meeting is open to the public. Authority: 42 U.S.C. 11225; Section 2(e)(3) of the National Alzheimer’s Project Act. The panel is governed by provisions of Public Law 92–463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. Buford Highway NE., Mailstop F63, Atlanta, Georgia 30341, Telephone: (770) 488–4281. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dana Redford, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Dated: March 22, 2013. Donald Moulds, Acting Assistant Secretary for Planning and Evaluation. [FR Doc. 2013–07428 Filed 4–3–13; 8:45 am] [FR Doc. 2013–07827 Filed 4–3–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review. The meeting announced below concerns Research Grants for Preventing Violence and Violence Related Injury, Funding Opportunity Announcement (FOA) CE13–002, Initial Review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned SEP: Time and Date: 9:00 a.m.–6:00 p.m., May 15–16, 2013 (Closed). Place: Georgian Terrace, 659 Peachtree Street NE., Atlanta, Georgia 30308. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Research Grants for Preventing Violence and Violence Related Injury, FOA CE13–002’’. Contact Person for More Information: Jane Suen, Dr.P.H., M.S., M.P.H., Scientific Review Officer, CDC, 4770 PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Conducting Public Health Research in Kenya, FOA GH10–003; Conducting Public Health Research in Thailand by the Ministry of Public Health (MOPH), FOA GH11–002; Conducting Public Health Research in China, FOA GH12–005; Strengthening Disease Prevention Research Capacity for Public Health Action in Guatemala and the Central American Region, FOA GH13–001; Strengthening the Monitoring and Evaluation of Programs for the Elimination and Control of Neglected Tropical Diseases in Africa, FOA GH13–002; Detecting Etiologies of Emerging Infectious Diseases at the Regional Level—Western Ghat Region of Karnataka and Kerala, India, FOA GH13–003; Strengthening Surveillance for Japanese Encephalitis in India, FOA GH13–004; Monitoring and Evaluation of Malaria Control and Elimination Activities, FOA GH13–005; and Research and Technical Assistance for Public Health Interventions in Haiti to Support Post-earthquake Reconstruction, Cholera and HIV/AIDS, FOA GH13–006, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 11:00 a.m.–5:00 p.m., May 6, 2013 (Closed) Place: Teleconference. Status: The meeting will be closed to the public in accordance with E:\FR\FM\04APN1.SGM 04APN1

Agencies

[Federal Register Volume 78, Number 65 (Thursday, April 4, 2013)]
[Notices]
[Page 20319]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-07827]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review.

    The meeting announced below concerns Research Grants for Preventing 
Violence and Violence Related Injury, Funding Opportunity Announcement 
(FOA) CE13-002, Initial Review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned SEP:
    Time and Date:
    9:00 a.m.-6:00 p.m., May 15-16, 2013 (Closed).
    Place: Georgian Terrace, 659 Peachtree Street NE., Atlanta, Georgia 
30308.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Research Grants for Preventing Violence and Violence Related 
Injury, FOA CE13-002''.
    Contact Person for More Information: Jane Suen, Dr.P.H., M.S., 
M.P.H., Scientific Review Officer, CDC, 4770 Buford Highway NE., 
Mailstop F63, Atlanta, Georgia 30341, Telephone: (770) 488-4281.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Dana Redford,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2013-07827 Filed 4-3-13; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.